ResearchSafe

DPT (N,N-Dipropyltryptamine)

Category: Psychedelics. Status: Schedule I (research compound).

A short-to-moderate acting tryptamine that has been explored in religious and end-of-life therapy settings. Effects are often described as intense and auditory.

How it works

Activates serotonin 5-HT2A receptors.

Key facts

  • Molecular weight: 244.38 g/mol
  • Half-life: Short
  • Bioavailability: Oral
  • Storage: Research/reference only.

Dosing overview

  • Typical dose: Varies by individual and setting
  • Frequency: Occasional
  • Duration: Acute effects last 2-4 hours
  • Route: Oral

Protocol notes

  • Insufflated, smoked or taken orally; has been used in guided religious and end-of-life settings.
  • Shorter than ayahuasca, but effects can be intense and disorienting.

Reported benefits

  • Explored in end-of-life therapy
  • Used in some religious contexts
  • Shorter than ayahuasca
  • Tryptamine research compound

Possible side effects

  • Intense, sometimes frightening experiences
  • Nausea
  • Raised heart rate
  • Limited human safety data

Compare DPT

Research and educational reference only. Not medical advice.